There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Denali Therapeutics Inc. (DNLI) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.49, or -1.98%, to $24.21. The Denali Therapeutics Inc. has recorded 7,356 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2023.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $24.70 and fluctuated between $24.98 as its day high and $23.69 as its day low. The current market capitalization of Denali Therapeutics Inc. is $3.36B. A total of 0.77 million shares were traded on the day, compared to an average of 650.29K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, DNLI has seen 2 BUY and 7 SELL insider trades, representing the acquisition of 60,000 and the disposition of 74,700 shares. Over the last 12 months, there were 25 BUYs and 42 SELLs from insiders. Insiders purchased 416,640 shares during that period but sold 296,543.
In the most recent transaction, Ho Carole sold 2,522 shares of DNLI for 23.22 per share on Aug 23. After the transaction, the Chief Medical Officer now owns 182,809 company shares. In a previous transaction on Aug 23, Schuth Alexander O. sold 2,522 shares at 23.17 per share. DNLI shares that COFO and Secretary owns now total 518,989.
Among the insiders who sold shares, Ho Carole disposed of 2,478 shares on Aug 21 at a per-share price of $22.60. This resulted in the Chief Medical Officer holding 185,331 shares of DNLI after the transaction. In another insider transaction, Schuth Alexander O. sold 2,478 shares at $22.59 per share on Aug 21. Company shares held by the COFO and Secretary now total 521,511.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for DNLI in the last 3 months, the mean price target is $54.57 with high estimates of $105.00 and low estimates of $26.00. In terms of 52-week highs and lows, DNLI has a high of $34.78 and a low of $21.74.
As of this writing, DNLI has an earnings estimate of -$0.83 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of -$0.65 per share and a lower estimate of -$1. The company reported an EPS of -$0.8 in the last quarter, which was -14.30% lower than expectations of -$0.7.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. DNLI’s latest balance sheet shows that the firm has $865.41M in Cash & Short Term Investments as of fiscal 2021. There were $58.55M in debt and $378.25M in liabilities at the time. Its Book Value Per Share was $8.66, while its Total Shareholder’s Equity was $962.29M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DNLI is Buy with a score of 4.69.